Company intelligence / Profile preview

LipidViro Tech

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

LipidViro Tech is a biotechnology company specializing in the development of advanced lipid nanoparticle (LNP) delivery systems for therapeutic and vaccine applications. The company focuses on optimizing the delivery of genetic material and other payloads to target specific tissues and cells, with a particular emphasis on addressing challenges in viral infections and infectious diseases. By leveraging its proprietary LNP technology, LipidViro Tech aims to enhance the stability, safety, and efficacy of next-generation medicines. The firm provides both internal R&D programs and potential partnership opportunities for customized delivery solutions.

Therapeutic areas: Infectious Diseases
Modalities: Lipid nanoparticle delivery therapyNanoparticleVaccine
Industry: Biotech

Beyond the preview

Go deeper on LipidViro Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LipidViro Tech.

Explore the full profile